News

The daily dose: October 27, 2021

| Updated on October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And this means, Bharat Biotech will have to wait for some more time before getting the Emergency Use tag from the World Health Organisation (WHO) for its Covid-19 vaccine.

WHO panel seeks additional clarifications from Bharat Biotech for Covaxin approval

# Zydus vaccine, priced higher? : Despite the hard bargain by the government, the final price of Zydus Cadila’s three-dose ZyCoV-D vaccine will be higher than Bharat Biotech’s Covaxin and Serum Institute’s Covishield.

Zydus Cadila’s DNA vaccine to be costlier than Covaxin, Covishield

# Back on Mumbai’s locals: The Maharashtra government has issued an order allowing fully-vaccinated people to board local trains.

Full vaccination ‘mandatory’ to board Maharashtra’s local trains

# Focussed on second dose: Health teams in Tamil Nadu districts have been given detailed instructions to focus on increasing daily vaccinations along with local bodies by following a saturation approach after identifying list of persons yet to take first dose and those eligible for second dose.

TN health teams to focus on increasing daily vaccination rate

# Reconciling mortality numbers: Covid-battered Kerala has taken a cue from others States to reconcile the death toll with the unreported or under-reported ones after initiating a review of the processes and procedures used so far to certify and take them on record.

With unmasked new death numbers, Kerala reconciles itself to Covid facts on ground

# Testing for severe disease: A Kochi-based biotechnology start-up has developed a test kit for genomic analysis that can apparently help predict chances of developing severe disease if infected.

Biotech start-up Sagenome develops test kit to predict Covid disease severity

# Kids dosage: Moderna has said that a low dose of its Covid-19 vaccine is safe and appears to work in 6 to 11-year-olds, as the manufacturer joins its rival Pfizer in moving towards expanding shots to children.

Moderna says its low-dose Covid shot works for kids 6 to 11

# US lifts travel curbs: The US will lift all travel restrictions for incoming non-citizen, non-immigrant travellers from November 8, with only limited exceptions, and they will be required to be fully vaccinated and produce proof of their Covid-19 vaccination prior to boarding a flight to the country, the White House announced on Monday.

US to lift all travel restrictions for incoming foreign nationals from Nov 8: White House

Published on October 27, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like